Generation of Haploid Stem Cells From Human Germ Cells
1 other identifier
observational
10
1 country
2
Brief Summary
Human cells are diploid (contain a double set of chromosomes). The diploid genome is complex and therefore limits genetic research approaches in biomedical models. To overcome this problem experimental generation of haploid stem cells has been done in animals. The investigators aim at generating haploid stem cells from human germ cells that are a useful tool in genetic research and screening.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2011
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 16, 2011
CompletedFirst Posted
Study publicly available on registry
October 19, 2011
CompletedStudy Start
First participant enrolled
December 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedDecember 11, 2013
December 1, 2013
3 years
October 16, 2011
December 10, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Patients donated samples
No samples collected to date
June 2011-November 2013
Secondary Outcomes (1)
No secomdary outcome
June 2011 - November 2013
Study Arms (1)
Sperm sample from healthy volunteers
Interventions
Collected germ cells will be cultured in medium. The germ cell cultures will be infected with reprograming factors. Rare colonies with characteristic stem cell morphologies will be expanded.
Eligibility Criteria
Male volunteers
You may qualify if:
- males over the age of 18 and under 50
- no known chronic illness
- not taking any chronic drugs
You may not qualify if:
- females
- males under 18 or over 50
- any known chronic illness
- taking chronic medications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Rambam medical center
Haifa, 30196, Israel
Weizmann institute of science
Rehovot, 76100, Israel
Biospecimen
Germ cells and Stem cells
Study Officials
- PRINCIPAL INVESTIGATOR
Itay Maza, M.D
Rambam Health Care Campus
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2011
First Posted
October 19, 2011
Study Start
December 1, 2011
Primary Completion
December 1, 2014
Study Completion
August 1, 2015
Last Updated
December 11, 2013
Record last verified: 2013-12